FMR LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$257,746,693
-61.0%
15,959,548
+0.2%
0.02%
-60.0%
Q2 2023$661,095,961
-65.2%
15,930,023
-49.6%
0.06%
-36.8%
Q1 2023$1,901,051,504
+64.7%
31,610,434
+100.9%
0.09%
-24.3%
Q4 2022$1,154,285,368
-1.6%
15,736,679
+1.9%
0.12%
-5.7%
Q3 2022$1,173,139,000
+34.6%
15,440,108
+23.1%
0.12%
+40.2%
Q2 2022$871,669,000
-1.9%
12,542,006
+16.9%
0.09%
+22.5%
Q1 2022$888,969,000
+51.7%
10,729,870
+37.5%
0.07%
+65.1%
Q4 2021$585,887,000
-39.1%
7,803,503
-5.7%
0.04%
-43.4%
Q3 2021$961,293,000
-54.9%
8,274,887
-14.0%
0.08%
-54.5%
Q2 2021$2,133,717,000
+77.6%
9,619,135
+5.8%
0.17%
+62.1%
Q1 2021$1,201,310,000
-27.9%
9,088,439
-5.6%
0.10%
-30.4%
Q4 2020$1,665,951,000
+50.3%
9,627,554
-3.3%
0.15%
+32.1%
Q3 2020$1,108,242,000
+79.0%
9,956,360
-4.6%
0.11%
+64.7%
Q2 2020$619,005,000
-22.4%
10,438,534
-11.8%
0.07%
-38.2%
Q1 2020$797,248,000
-22.3%
11,839,159
-2.8%
0.11%
-2.7%
Q4 2019$1,026,360,000
+15.3%
12,179,429
+2.3%
0.11%
+5.6%
Q3 2019$890,258,000
+36.7%
11,905,031
+15.5%
0.11%
+40.8%
Q2 2019$651,477,000
+29.6%
10,303,298
-1.3%
0.08%
+26.7%
Q1 2019$502,783,000
+34.2%
10,437,688
-6.7%
0.06%
+17.6%
Q4 2018$374,654,000
-34.1%
11,190,381
+3.2%
0.05%
-20.3%
Q3 2018$568,292,000
+130.9%
10,845,246
+37.9%
0.06%
+128.6%
Q2 2018$246,084,000
+61.7%
7,862,121
+12.6%
0.03%
+55.6%
Q1 2018$152,171,000
-6.6%
6,980,345
-13.5%
0.02%
-5.3%
Q4 2017$162,937,000
+5.3%
8,066,199
+3.5%
0.02%0.0%
Q3 2017$154,769,000
+29.9%
7,796,935
+13.2%
0.02%
+26.7%
Q2 2017$119,165,000
+221.3%
6,888,120
+50.4%
0.02%
+200.0%
Q1 2017$37,086,000
-3.4%
4,578,561
-6.4%
0.01%0.0%
Q4 2016$38,384,000
-7.9%
4,889,661
+0.2%
0.01%
-16.7%
Q3 2016$41,666,000
-28.5%
4,878,970
-2.3%
0.01%
-25.0%
Q2 2016$58,304,000
-27.1%
4,996,021
-9.6%
0.01%
-27.3%
Q1 2016$80,005,000
-30.9%
5,525,221
+6.7%
0.01%
-31.2%
Q4 2015$115,767,0005,177,4030.02%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders